170 related articles for article (PubMed ID: 20037446)
41. [Efficacy of neoadjuvant chemotherapy for pancreatic carcinoma planned resection].
Motoi F; Unno M
Nihon Rinsho; 2015 Mar; 73 Suppl 3():152-8. PubMed ID: 25857005
[No Abstract] [Full Text] [Related]
42. Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.
Okada K; Imaizumi T; Yazawa N; Matsuyama M; Dowaki S; Tobita K; Hirabayashi K; Makuuchi H
Tokai J Exp Clin Med; 2009 Jul; 34(2):53-7. PubMed ID: 21318999
[TBL] [Abstract][Full Text] [Related]
43. [Regrowth of Isolated Local Residual Tumor Effectively Treated with Chemoradiotherapy More Than Five Years after a Resection for Pancreatic Cancer with an Involvement of the Portal Vein].
Matsumura T; Totsuka E; Kitamura K; Okada K; Inose S; Koyama M; Nakamura N; Masamura S; Karikomi K; Suwa T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2344-2346. PubMed ID: 28133316
[TBL] [Abstract][Full Text] [Related]
44. Total pancreatoduodenectomy en bloc with superior mesenteric artery and vein resection after gemcitabine and nab-paclitaxel neoadjuvancy.
Vicente E; Quijano Y; Ielpo B; Duran H
Surg Oncol; 2017 Sep; 26(3):276-277. PubMed ID: 29804945
[TBL] [Abstract][Full Text] [Related]
45. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
[TBL] [Abstract][Full Text] [Related]
46. Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.
Okusaka T; Miyakawa H; Fujii H; Nakamori S; Satoh T; Hamamoto Y; Ito T; Maguchi H; Matsumoto S; Ueno H; Ioka T; Boku N; Egawa S; Hatori T; Furuse J; Mizumoto K; Ohkawa S; Yamaguchi T; Yamao K; Funakoshi A; Chen JS; Cheng AL; Sato A; Ohashi Y; Tanaka M;
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1053-1059. PubMed ID: 28210843
[TBL] [Abstract][Full Text] [Related]
47. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
[TBL] [Abstract][Full Text] [Related]
48. Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial.
Motoi F; Ishida K; Fujishima F; Ottomo S; Oikawa M; Okada T; Shimamura H; Takemura S; Ono F; Akada M; Nakagawa K; Katayose Y; Egawa S; Unno M
Ann Surg Oncol; 2013 Nov; 20(12):3794-801. PubMed ID: 23838925
[TBL] [Abstract][Full Text] [Related]
49. [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
Iwauchi T; Amano R; Ohira G; Nakamoto K; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2373-5. PubMed ID: 21224577
[TBL] [Abstract][Full Text] [Related]
50. A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Saito K; Isayama H; Nakai Y; Takahara N; Ishigaki K; Takeda T; Hakuta R; Saito T; Uchino R; Kishikawa T; Hamada T; Mizuno S; Sasaki T; Kogure H; Matsubara S; Yamamoto N; Ijichi H; Tateishi K; Tada M; Koike K
Invest New Drugs; 2019 Apr; 37(2):338-344. PubMed ID: 30411217
[TBL] [Abstract][Full Text] [Related]
51. A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer.
Nakai Y; Isayama H; Sasaki T; Sasahira N; Ito Y; Kogure H; Togawa O; Matsubara S; Arizumi T; Yagioka H; Yashima Y; Kawakubo K; Mizuno S; Yamamoto K; Hirano K; Tsujino T; Ijichi H; Toda N; Tada M; Kawabe T; Omata M
Oncology; 2009; 77(5):300-3. PubMed ID: 19923869
[TBL] [Abstract][Full Text] [Related]
52. [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Ohara T; Fujino Y; Goto H; Yamashita H; Oyama M; Katsura M; Sugiyama H; Ueda Y; Hasegawa H; Yasuda T; Kakinoki K; Oshikiri T; Sendo H; Sugimoto T; Tominaga M
Gan To Kagaku Ryoho; 2015 May; 42(5):633-5. PubMed ID: 25981662
[TBL] [Abstract][Full Text] [Related]
53. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
Motoi F; Satoi S; Honda G; Wada K; Shinchi H; Matsumoto I; Sho M; Tsuchida A; Unno M;
J Gastroenterol; 2019 Feb; 54(2):194-203. PubMed ID: 30182219
[TBL] [Abstract][Full Text] [Related]
54. A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact.
Kondo N; Uemura K; Sudo T; Hashimoto Y; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
Eur J Cancer; 2021 Dec; 159():215-223. PubMed ID: 34781169
[TBL] [Abstract][Full Text] [Related]
55. [Two Case Reports of Chemotherapy-Induced Radiation Myositis].
Nishibuchi I; Wadasaki K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):1005-1007. PubMed ID: 30026433
[TBL] [Abstract][Full Text] [Related]
56. [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Ohta H; Doi T; Kikuchi S; Sato Y; Okuda T; Fujimi A; Kanisawa Y; Izumi K; Kitahara T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1489-92. PubMed ID: 17876153
[TBL] [Abstract][Full Text] [Related]
57. Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection.
Shimoda M; Kubota K; Shimizu T; Katoh M
Br J Surg; 2015 Jun; 102(7):746-54. PubMed ID: 25833230
[TBL] [Abstract][Full Text] [Related]
58. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
Koga H; Miyoshi A; Nakamura J; Ide T; Kitahara K; Noshiro H
Gan To Kagaku Ryoho; 2014 May; 41(5):665-8. PubMed ID: 24917019
[TBL] [Abstract][Full Text] [Related]
59. A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.
Oh DY; Cha Y; Choi IS; Yoon SY; Choi IK; Kim JH; Oh SC; Kim CD; Kim JS; Bang YJ; Kim YH
Cancer Chemother Pharmacol; 2010 Feb; 65(3):527-36. PubMed ID: 19578850
[TBL] [Abstract][Full Text] [Related]
60. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
